(Q37920537)

25 August 2017

1 reference

title

Therapeutic potential of adenosine analogues and conjugates (English)

1 reference

25 August 2017

2

Krystyna Dzierzbicka

1 reference

25 August 2017

Monika Samsel

1

1 reference

25 August 2017

language of work or name

1 reference

1 May 2011

1 reference

25 August 2017

published in

Pharmacological Reports

1 reference

25 August 2017

volume

63

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

601-617

1 reference

Stability study of selected adenosine nucleosides using LC and LC/MS analyses

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

The resurgence of A2B adenosine receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Regadenoson: a new myocardial stress agent

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Recent improvements in the development of A(2B) adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Advances in pharmacologic agents in imaging: new A2A receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Pharmacology and therapeutic applications of A1 adenosine receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A(2B) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A2B adenosine receptor dampens hypoxia-induced vascular leak

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A1 adenosine receptor agonists and their potential therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Striatal adenosine A2A receptors--where are they? What do they do?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine and lymphocyte regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Oxidant stress and damage in post-ischemic mouse hearts: effects of adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine stimulates fibroblast growth factor-7 gene expression via adenosine A2b receptor signaling in dermal papilla cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A new generation of coronary vasodilators in stress perfusion imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Expression of adenosine A2a receptors gene in the olfactory bulb and spinal cord of rat and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Blockade of adenosine A2B receptors ameliorates murine colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine: an endogenous modulator of innate immune system with therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Bisubstrate inhibitors of protein kinases: from principle to practical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A physiological role of the adenosine A3 receptor: sustained cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Tonic activity of the rat adipocyte A1-adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Design and application of locally delivered agonists of the adenosine A(2A) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

The adenosinergic immunomodulatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Designing bisubstrate analog inhibitors for protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine receptors: new opportunities for future drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Polyamine transport in parasites: a potential target for new antiparasitic drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Determination of Adenosine Effects and Adenosine Receptors in Murine Corpus Cavernosum

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine A3 receptor stimulation and cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Regulated expression of an essential allosteric activator of polyamine biosynthesis in African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Potential roles of a special CD8 alpha alpha+ cell population and CC chemokine thymus-expressed chemokine in ovulation related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Adenosine signaling and the regulation of chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970573-4

7 January 2021

10.1016/S1734-1140(11)70573-4

Identifiers

DOI

1 reference

25 August 2017

1 reference